US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
You may also like
Gainers
Latest Crypto News
「Whale」 Ethereum Multi-Step again Partially Liquidated, Account Balance Fell Below $270,000
Cryptocurrency Fear and Greed Index Drops to 24, Market Enters "Extreme Fear" Mode Again
「Cool-headed King of Shorting」 entered a new MON short position, earlier this morning closed a long position on BTC and SOL before reversing to open a short position
In the past 4 hours, the entire network has seen $435 million in liquidations, with longs accounting for $424 million of the total.
「CZ's Countertrade」 Long Position's Unrealized Loss Expands to $26 Million, Now the Largest Long on Hyperliquid for ETH and XRP
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:[email protected]
VIP Services:[email protected]